The top 10: PDL advice columns
Risk assessment, getting your workflow and systems right, vax planning and more… which PDL columns have caught our readers’ attention this year? These were the ten most read PDL columns …
The top 10: Clinical news
Which clinical pharmacy stories were our readers interested in during the first half of the year? These were the 10 most clicked clinical news articles during the first half of …
Celebrating a long history
150 years of pharmacy history celebrated during Sydney event to honour the role of PSNSWÂ The Pharmaceutical Society of NSW (PSNSW) recently celebrated its 150th birthday in grand style with …
The top 10: Business Class
Tax, super, employer wish lists, work-life balance and more. We look at our most read business columns during the first six months of 2026Â Â These are the ten most opened …
July MIMS update
Some recent changes to medicines listings, including new products, presentations, indications, contraindications and safety changes New products Abaloparatide (Eladynos) is an agonist of the parathyroid hormone receptor 1 (PTHR1). It …
The top 10
Surveillance fears and pay issues top our latest monthly most read stories list These were the most read stories on the AJP website between 10 June and 10 July: CWH …
The top 10: Longer reads
Closures, business collapses, GLP-1s and more: our ten most viewed longer read articles during the first half of 2026Â The closure of a beloved community institution, a detailed look at …
The top 10: Education
Which of our CPD articles have most captured reader interest during the first six months of 2026? These were our best read education articles during the first half of 2026: …
The top 25 of 2026 (so far)
Pharmacy group collapse dominates our most read stories list in the first half of 2026 The Infinity Pharmacy group collapse dominates our list of the 25 most read stories on …
June MIMS update
The latest in medicines news from MIMS, with new products, presentations, indications and safety changes New products Loncastuximab tesirine (Zynlonta) is an antibody-drug conjugate (ADC) targeting CD19. The monoclonal immunoglobulin …
Mentorship and learning, it’s a lifelong thing
A sneak peek at some of the topics of note in our July AJP edition, where we examine what makes a successful mentor relationship If I look back on my …
Getting consistent with childhood vaccinations
Growth of pharmacist-administered vaccination is highlighting regulatory and funding inconsistencies, say researchers Australia needs a nationally harmonised regulatory framework for pharmacist-administered vaccinations, say researchers who have conducted a review of …